Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04321512 · ClinicalTrials.gov registry record
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
A clinical trial of Myocardial Infarction and Stroke, Ischemic, sponsored by UConn Health.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04321512: Recruiting study of Myocardial Infarction and Stroke, Ischemic, sponsored by UConn Health.
NCT04321512 is a study of Myocardial Infarction and Stroke, Ischemic that is actively recruiting participants, run by UConn Health. The registered enrollment target is 300 participants, below the 4,677-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04321512, a study of Myocardial Infarction and Stroke, Ischemic, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to discover the functions of circulating white blood cells, called monocytes, and associated circulating substances in heart attack and ischemic stroke patients. Ischemic Strokes (clots) occur as a result of an obstruction within a blood vessel supplying blood to the brain. A type of monocyte carrying a surface marker called "P2X4" helps the immune system sense and respond to danger signals from the body such as heart muscle and brain tissue injuries. The researchers expect to learn more about how these monocyte cells react to heart and brain tissue injury, and how the cells may then produce proteins or other chemical substances which promote the healing of heart muscle after heart attack and brain tissue after an ischemic stroke.
Primary Outcome
myocardial infarction, stroke or death
Conditions Studied
Interventions
- OTHER There is no intervention given to the subjects
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2027-12-01 |
What NCT04321512 shows while recruiting
NCT04321512 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 4,677-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention given to the subjects is the first listed.
NCT04321512 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04321512 about?
NCT04321512 is a clinical study titled "Study of Circulating Monocytes in Patients With Ischemic Vascular Disease". The purpose of this research study is to discover the functions of circulating white blood cells, called monocytes, and associated circulating substances in heart attack and ischemic stroke patients. Ischemic Strokes (clots) occur as a result of an obstruction within a blood vessel supplying blood t...
What is the current status of trial NCT04321512?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2013-12-01. Estimated completion is 2027-12-01.
What conditions does trial NCT04321512 study?
This clinical trial studies the following conditions: Myocardial Infarction, Stroke, Ischemic, Ischemia.
What interventions are being tested in trial NCT04321512?
The interventions under investigation include: There is no intervention given to the subjects (OTHER).
Who is sponsoring clinical trial NCT04321512?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04321512 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04321512's enrollment target sits among peer trials
300 39th of 64 higher than 26 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI